RECURRENT ECTOMESENCHYMOMA

Clinical trials for RECURRENT ECTOMESENCHYMOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT ECTOMESENCHYMOMA trials appear

Sign up with your email to follow new studies for RECURRENT ECTOMESENCHYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for kids with tough cancers: trial targets a key genetic driver

Disease control Ongoing

This study is testing a drug called tipifarnib in children and young adults whose advanced cancers have a specific genetic change in a gene called HRAS. The goal is to see if the drug can shrink tumors and control the disease. Participants take the drug as a pill or through a fee…

Matched conditions: RECURRENT ECTOMESENCHYMOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

RECURRENT ECTOMESENCHYMOMA

Get alerted when new RECURRENT ECTOMESENCHYMOMA trials appear

New hope for kids with tough cancers: trial targets a key genetic driver